Collecting data on proton therapy for cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to prospectively gather high-quality data on patients undergoing proton therapy for various oncological conditions. It focuses on understanding the feasibility and clinical outcomes of hypofractionated treatment schedules. The study will implement a three-level data collection approach, including clinical outcomes, radiological analysis, and biological research. By addressing the current lack of robust evidence in proton therapy, this registry seeks to enhance knowledge and improve treatment protocols.

Why it matters

Who can join: the full rules

Inclusion criteria:

* diagnosis of oncological disease (benign and malignant disease);
* candidates to proton therapy;
* able to provide informed consent.

Exclusion criteria:

\- age \< 18 years.

Where it's running

• European Institute of Oncology
  Milan, Italy Recruiting

Study contacts

• Principal investigator: Roberto Orecchia — European Institute of Oncology
• Study coordinator: Roberto Orecchia, Prof
• Email: roberto.orecchia@ieo.it
• Phone: +39 0257489578

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding what patients want from NSCLC treatment monitoring

  Researchers are testing how patients with non-small cell lung cancer feel about and prefer monitoring their symptoms during treatment, with input from patients, caregivers, and clinicians.

  Recruiting European Institute of Oncology · Milan, mI · NCT07909343

• Single-Port Robotic Lobectomy for Early-Stage NSCLC

  This study tests the safety and outcomes of using the da Vinci Single-Port system for lobectomy and lymph node dissection in people with early-stage non-small cell lung cancer.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07790406

• Disparities in Mental Health Screening and Support for Cancer Patients and Families

  This study tests whether cancer patients and their families across Europe have equal access to mental health screening and support services.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07691281

• Melanoma Brain Metastases Treated with Stereotactic Radiosurgery and Systemic Therapy

  This study looks at how stereotactic radiosurgery for melanoma brain metastases works when patients are also receiving immunotherapy or targeted therapy.

  Recruiting at 2 sites European Institute of Oncology · Milan, Italy and 1 other locations · NCT07691255

• Predictive biomarkers for immunotherapy in endometrial cancer

  This study tests molecular and epigenetic features to see if they can predict which endometrial cancer patients will respond to immune checkpoint inhibitors.

  Recruiting European Institute of Oncology · Milan, Italy · NCT07690540

• See if Italian patients with cancer experience MRI anxiety and how a translated questionnaire works

  This study tests whether an Italian version of an MRI anxiety questionnaire reliably measures anxiety in adults with cancer undergoing whole-body MRI.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07671846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.